 you know, has to say is that, I mean, that is fair, Roger. Absolutely. It's, it's sort of like with, you know, I, there are a lot of parallels with trade agreements act and country of origin considerations here. When we look at biosecure, it's really on the company to take, to be mindful at the early stages when these partnerships are considered it, if you're waiting for the government to tell you that you can't use, um,